Diabetic retinopathy screening outcomes by patient characteristics

Standard shorthand is used in this table: [t] = total, [z] = not applicable.

View options

Filters

Data description ( of 2 selected2 selectable options)

Date ( of 12 selected12 selectable options)

Characteristics ( of 9 selected9 selectable options)

Outcome ( of 6 selected6 selectable options)


Data valuesData descriptionDateCharacteristicsOutcome
218Number31/03/2023Gender: MaleSevere retinopathy/maculopathy
315Number31/03/2025Gender: FemaleSevere retinopathy/maculopathy
109Number31/03/2020Age: 70-79 yearsSevere retinopathy/maculopathy
335 [t]Number31/03/2023Gender: TotalSevere retinopathy/maculopathy
254Number31/03/2024Gender: FemaleSevere retinopathy/maculopathy
528Number31/03/2025Gender: MaleSevere retinopathy/maculopathy
585 [t]Number31/03/2020Gender: TotalSevere retinopathy/maculopathy
141Number31/03/2020Age: 60-69 yearsSevere retinopathy/maculopathy
105Number31/03/2021Age: 60-69 yearsSevere retinopathy/maculopathy
60Number31/03/2022Age: 80 years or overSevere retinopathy/maculopathy
68Number31/03/2023Age: 70-79 yearsSevere retinopathy/maculopathy
467Number31/03/2024Gender: MaleSevere retinopathy/maculopathy
117Number31/03/2024Age: 70-79 yearsSevere retinopathy/maculopathy
843 [t]Number31/03/2025Gender: TotalSevere retinopathy/maculopathy
0Number31/03/2019Age: 19 years and underSevere retinopathy/maculopathy
102Number31/03/2019Age: 80 years or overSevere retinopathy/maculopathy
585 [t]Number31/03/2020Age: TotalSevere retinopathy/maculopathy
260Number31/03/2020Age: 20-59 yearsSevere retinopathy/maculopathy
306Number31/03/2021Gender: FemaleSevere retinopathy/maculopathy
263Number31/03/2021Age: 20-59 yearsSevere retinopathy/maculopathy
321Number31/03/2022Gender: MaleSevere retinopathy/maculopathy
98Number31/03/2022Age: 70-79 yearsSevere retinopathy/maculopathy
117Number31/03/2023Gender: FemaleSevere retinopathy/maculopathy
61Number31/03/2023Age: 60-69 yearsSevere retinopathy/maculopathy
722 [t]Number31/03/2024Gender: TotalSevere retinopathy/maculopathy
152Number31/03/2018Age: 80 years or overSevere retinopathy/maculopathy
722 [t]Number31/03/2024Age: TotalSevere retinopathy/maculopathy
158Number31/03/2024Age: 60-69 yearsSevere retinopathy/maculopathy
278Number31/03/2019Gender: FemaleSevere retinopathy/maculopathy
74Number31/03/2024Age: 80 years or overSevere retinopathy/maculopathy
881Number31/03/2018Gender: MaleSevere retinopathy/maculopathy
326Number31/03/2018Age: 70-79 yearsSevere retinopathy/maculopathy
135Number31/03/2017Age: 70-79 yearsSevere retinopathy/maculopathy
152Number31/03/2019Age: 70-79 yearsSevere retinopathy/maculopathy
102Number31/03/2017Age: 80 years or overSevere retinopathy/maculopathy
189Number31/03/2020Gender: FemaleSevere retinopathy/maculopathy
0Number31/03/2020Age: 19 years and underSevere retinopathy/maculopathy
81Number31/03/2016Age: 70-79 yearsSevere retinopathy/maculopathy
75Number31/03/2020Age: 80 years or overSevere retinopathy/maculopathy
140Number31/03/2021Gender: MaleSevere retinopathy/maculopathy
448 [t]Number31/03/2021Age: TotalSevere retinopathy/maculopathy
1Number31/03/2021Age: 19 years and underSevere retinopathy/maculopathy
58Number31/03/2021Age: 70-79 yearsSevere retinopathy/maculopathy
537 [t]Number31/03/2022Gender: TotalSevere retinopathy/maculopathy
537 [t]Number31/03/2022Age: TotalSevere retinopathy/maculopathy
140Number31/03/2022Age: 60-69 yearsSevere retinopathy/maculopathy
265Number31/03/2017Gender: FemaleSevere retinopathy/maculopathy
753 [t]Number31/03/2019Gender: TotalSevere retinopathy/maculopathy
335 [t]Number31/03/2023Age: TotalSevere retinopathy/maculopathy
160Number31/03/2023Age: 20-59 yearsSevere retinopathy/maculopathy
505 [t]Number31/03/2014Gender: TotalSevere retinopathy/maculopathy
46Number31/03/2023Age: 80 years or overSevere retinopathy/maculopathy
47Number31/03/2014Age: 80 years or overSevere retinopathy/maculopathy
485 [t]Number31/03/2016Gender: TotalSevere retinopathy/maculopathy
741 [t]Number31/03/2017Age: TotalSevere retinopathy/maculopathy
753 [t]Number31/03/2019Age: TotalSevere retinopathy/maculopathy
472Number31/03/2019Gender: MaleSevere retinopathy/maculopathy
373Number31/03/2024Age: 20-59 yearsSevere retinopathy/maculopathy
562 [t]Number31/03/2015Gender: TotalSevere retinopathy/maculopathy
1Number31/03/2014Age: 19 years and underSevere retinopathy/maculopathy
211Number31/03/2016Age: 20-59 yearsSevere retinopathy/maculopathy
1Number31/03/2017Age: 19 years and underSevere retinopathy/maculopathy
314Number31/03/2016Gender: MaleSevere retinopathy/maculopathy
131Number31/03/2016Age: 60-69 yearsSevere retinopathy/maculopathy
373Number31/03/2015Gender: MaleSevere retinopathy/maculopathy
62Number31/03/2016Age: 80 years or overSevere retinopathy/maculopathy
180Number31/03/2017Age: 60-69 yearsSevere retinopathy/maculopathy
0Number31/03/2016Age: 19 years and underSevere retinopathy/maculopathy
321Number31/03/2019Age: 20-59 yearsSevere retinopathy/maculopathy
178Number31/03/2019Age: 60-69 yearsSevere retinopathy/maculopathy
181Number31/03/2015Gender: FemaleSevere retinopathy/maculopathy
254Number31/03/2014Age: 20-59 yearsSevere retinopathy/maculopathy
173Number31/03/2014Gender: FemaleSevere retinopathy/maculopathy
393Number31/03/2020Gender: MaleSevere retinopathy/maculopathy
163Number31/03/2016Gender: FemaleSevere retinopathy/maculopathy
1,397 [t]Number31/03/2018Gender: TotalSevere retinopathy/maculopathy
562 [t]Number31/03/2015Age: TotalSevere retinopathy/maculopathy
116Number31/03/2015Age: 70-79 yearsSevere retinopathy/maculopathy
1,397 [t]Number31/03/2018Age: TotalSevere retinopathy/maculopathy
485 [t]Number31/03/2016Age: TotalSevere retinopathy/maculopathy
473Number31/03/2017Gender: MaleSevere retinopathy/maculopathy
448 [t]Number31/03/2021Gender: TotalSevere retinopathy/maculopathy
0Number31/03/2015Age: 19 years and underSevere retinopathy/maculopathy
122Number31/03/2014Age: 60-69 yearsSevere retinopathy/maculopathy
490Number31/03/2018Gender: FemaleSevere retinopathy/maculopathy
56Number31/03/2015Age: 80 years or overSevere retinopathy/maculopathy
0Number31/03/2018Age: 19 years and underSevere retinopathy/maculopathy
305Number31/03/2018Age: 60-69 yearsSevere retinopathy/maculopathy
271Number31/03/2015Age: 20-59 yearsSevere retinopathy/maculopathy
21Number31/03/2021Age: 80 years or overSevere retinopathy/maculopathy
216Number31/03/2022Gender: FemaleSevere retinopathy/maculopathy
741 [t]Number31/03/2017Gender: TotalSevere retinopathy/maculopathy
594Number31/03/2018Age: 20-59 yearsSevere retinopathy/maculopathy
239Number31/03/2022Age: 20-59 yearsSevere retinopathy/maculopathy
119Number31/03/2015Age: 60-69 yearsSevere retinopathy/maculopathy
81Number31/03/2014Age: 70-79 yearsSevere retinopathy/maculopathy
505 [t]Number31/03/2014Age: TotalSevere retinopathy/maculopathy
323Number31/03/2017Age: 20-59 yearsSevere retinopathy/maculopathy
321Number31/03/2014Gender: MaleSevere retinopathy/maculopathy
843 [t]Number31/03/2025Age: TotalSevere retinopathy/maculopathy
Showing 1 to 100 of 1,180 rows
Page 1 of 12

Main information

Most recent update
30 September 2025
Next update expected
September 2026
Designation
Official statistics
Data provider
Diabetic Eye Screening Wales (DESW)
Data source
No specific source from data provider
Time period covered
March 2014 to March 2025

Data notes

Overview

Summary of dataset and variables

This dataset shows the outcomes from Diabetic Eye Screening Wales (DESW) screenings, broken down by patient characteristics such as sex and age group, and by financial year. It provides insight into how screening results vary across different population groups and over time.

Data collection or calculation

Aggregated counts of patients are derived from patient records and used as information to manage the DESW and have been provided for this statistical release. No data relating to individual patients has been transferred in this process. When a patient is diagnosed with diabetes by a GP, a referral is sent to DESW and the patient is registered and invited for screening. Screening is carried out in a mobile unit or healthcare sites. Patient information, including retinal images, is stored on the DESW database. DESW validates the database monthly against the Welsh Demographic Service to ensure that it is aligned with living Welsh residents. Total counts are also routinely validated against GP diabetes disease registers. The different outcomes in the dataset are determined by the ‘worst grade’ code assigned at each diabetic eye screening. This code identifies the extent of retinopathy. All screenings, including those with unreported outcomes, are included in the total ‘results reported’. The number of screenings resulting in each outcome is broken down by age group and gender, and the percentage of each outcome within these groups is also calculated.

Statistical quality

For some years, all screenings with severe retinopathy/maculopathy were urgently referred to hospital eye services and so the numbers for both categories are the same. Note that there are small amounts of missing data within some fields of the DESW statistics. Percentages are calculated of records with stated values. The outcomes of a number of screenings were ungradeable in each year (usually between 2,000 and 3,000). On 1 April 2019, health service responsibility for Bridgend residents moved from Abertawe Bro Morgannwg to Cwm Taf. Health board names also changed: Cwm Taf became Cwm Taf Morgannwg, and Abertawe Bro Morgannwg became Swansea Bay. See the weblinks section for official statements.

Published by

Organisation
Welsh Government
Contact email
stats.healthinfo@gov.wales

Select the filtered or whole dataset to download

Select download format

Contains only the dataset
Contains only the dataset
Contains only the dataset

Select number formatting

This includes rounding to decimal places and commas to separate thousands
This includes rounding to decimal places and commas to separate thousands

Select language